With 4,690 clinical studies investigating new treatments for 1,843 diseases, Mexico ranks second in Latin America in this type of research, far behind Brazil, which has registered twice as many studies with 9,200 studies. .
While worldwide, the leader is the United States, with over 160,000 clinical studies, followed by all of Europe and China.
According to Paulina Lisaga, director of the Clinical Studies Unit of Sanofi Mexico, the main research focuses in Mexico, in proportion to about 40% of the total category, are in diseases of the immune system, followed by diseases of the respiratory tract. ,
“But there are also hundreds of studies for other conditions on the extensive list, including those that require highly specialized medicine, to find new answers for patients with the main conditions that concern us in Mexico: heart disease.” , diabetes and cancer,” he explained.
“In Mexico, there is a minimal share of preclinical research reported in ClinicalTrials.gov, only 17 studies. There are just over a thousand in phases one and two and about 2,500 in the most advanced, three and four.
“But there are other scientific studies outside this classification, 637 in total, and they analyze cases such as the effects of drinking Jamaican water or coffee in people who are obese or overweight,” he said.
According to the expert, when consulting the database of clinical studies on ClinicalTrials.gov, it is striking that the proportion of studies 96% versus 92% has a greater participation of women than men.
A clinical study is a scientific research project focused on obtaining data on the efficacy and safety of a drug, device, or vaccine under development. Participation in a clinical project should be voluntary and accompanied by an informed decision about the potential risks and benefits.